Can a Plant-Based protein switch reshape your metabolism?
NCT ID NCT04236518
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial investigates how replacing animal proteins with plant proteins in the diet influences metabolism. Adults with early signs of metabolic syndrome (like high triglycerides or slightly elevated blood pressure) will follow a controlled diet for four weeks, either predominantly animal or plant protein. At the end, they'll consume a high-fat, high-sugar meal, and blood and urine samples will be analyzed to see how their bodies respond. The goal is to understand the metabolic changes that might come from eating more plant-based proteins.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Controlled diets with predominantly animal or plant protein sources
- What this could lead to
- If successful, this could help explain how shifting from animal to plant proteins affects metabolism, potentially guiding dietary advice for people at risk of metabolic syndrome.
- What could go wrong
- This is a small, exploratory study (53 participants) that measures metabolic markers, not long-term health outcomes. Results may not apply to everyone, and the diets are highly controlled, which may not reflect real-world eating habits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
53 people
The number who actually took part.
- Started
-
Aug 2020
- Finished
-
Aug 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BMI between 25 and 35 kh/m² (terminals included) * Waist circumference ≥ 94 cm for men and ≥80 cm for women * at the choice, one of the following criteria: Triglyceridemia \> 1.49g/L, fasting blood glucose≥ 5.6 mmol/L , a HDL cholesterol \<1.03mmol/L for men or \<1.29 mmol/L for women , systolic blood pressure≥ 130 mmHg or diastolic≥ 85 mmHg . Exclusion Criteria: * Systolic blood pressure \> 150mmHg or diastolic blood pressure \> 90mmHg * pathology and medical treatment * diabetes * Smoking \> 4 cigarettes /day * Alcohol consumption \> 2 glasses/day * Antibiotics taken during the last 3 months before the clinical trial * Specific diets
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fasting blood sugar above normal are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Omega-3 metabolite put to the test for Post-Meal blood fats
- Which exercise dose best helps kids with metabolic syndrome?
- Can a weekly weight drug quiet gout attacks?
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
- Ketogenic diet vs mediterranean diet: which better reshapes metabolism?
- Can tailoring bypass length improve weight loss surgery results?